Compounding Flashcards
7 cards from real Pharmacy practice questions. Tap to flip, then mark Knew It or Still Learning โ missed cards come back until you master them.
Read the first 7 Compounding flashcards as text
A compounder needs to prepare 200 mL of a 2% w/v solution from a 10% w/v stock solution. How many mL of stock solution are needed?
Answer: 40 mL
Using C1V1 = C2V2: (10%)(V1) = (2%)(200 mL), so V1 = 40 mL.
According to USP , Category 1 CSPs (compounded sterile preparations) with no antimicrobial preservative stored at room temperature have a BUD of:
Answer: 24 hours
USP (2023) assigns a 24-hour BUD at controlled room temperature for Category 1 CSPs without antimicrobial preservatives.
Which type of water is required for preparing compounded sterile preparations (CSPs)?
Answer: Sterile Water for Injection (WFI)
Sterile Water for Injection (WFI) meets USP standards for sterility, pyrogen limits, and ionic purity required for CSPs.
When compounding a capsule, what excipient is commonly added as a glidant to improve powder flow?
Answer: Colloidal silicon dioxide (Cab-O-Sil)
Colloidal silicon dioxide functions as a glidant by reducing interparticulate friction and improving powder flow in capsule filling.
A pharmacy must conduct media-fill testing when performing sterile compounding. The primary purpose is to:
Answer: Verify the aseptic technique of the compounder
Media-fill testing uses a growth medium in place of the drug to simulate the compounding process and verify that the compounder's aseptic technique does not introduce contamination.
Which packaging material is preferred for light-sensitive compounded preparations?
Answer: Amber glass or amber plastic containers
Amber glass or plastic protects photosensitive preparations by blocking UV and visible light wavelengths that cause degradation.
According to USP , which category of hazardous drugs requires full containment controls (C-PEC + C-SEC) even for non-sterile compounding?
Answer: NIOSH Table 1 antineoplastic drugs
NIOSH Table 1 antineoplastic (chemotherapy) agents require the highest level of containment engineering controls under USP .